| SNRPD3 |
SNRPD3: Small nuclear ribonucleoprotein Sm D3 |
DDX20 |
DDX20, DP103, GEMIN3: Probable ATP-dependent RNA helicase DDX20 |
13.490 |
Evidence |
O
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
STAT3 |
|
13.490 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
PRKCQ |
PRKCQ, PRKCT: Protein kinase C theta type |
13.490 |
Evidence |
|
| GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
PTPN12 |
PTPN12: Tyrosine-protein phosphatase non-receptor type 12 |
13.490 |
Evidence |
|
| CCNE1 |
CCNE1, CCNE: G1/S-specific cyclin-E1 |
CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
13.490 |
Evidence |
|
| SNRPD3 |
SNRPD3: Small nuclear ribonucleoprotein Sm D3 |
GEMIN5 |
GEMIN5: Gem-associated protein 5 |
13.490 |
Evidence |
O
|
| CDC2 |
CDC2: Cell division control protein 2 homolog |
CCNB1 |
Cyclin B1 |
13.490 |
Evidence |
O
|
| YWHAZ |
YWHAZ: 14-3-3 protein zeta/delta |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
13.490 |
Evidence |
|
| PLK1 |
PLK1, PLK: Serine/threonine-protein kinase PLK1 |
CCNB1 |
Cyclin B1 |
13.490 |
Evidence |
|
| KPNA2 |
KPNA2, RCH1, SRP1: Importin subunit alpha-2 |
RELA |
RELA, NFKB3: Transcription factor p65 |
13.450 |
Evidence |
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
13.360 |
Evidence |
O
|
| F2 |
F2: Prothrombin precursor |
GP5 |
GP5: Platelet glycoprotein V precursor |
13.320 |
Evidence |
|
| EFNA3 |
EFNA3, EFL2, EPLG3, LERK3: Ephrin-A3 precursor |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
13.270 |
Evidence |
|
| EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
EPHB6 |
EPHB6: Ephrin type-B receptor 6 precursor |
13.270 |
Evidence |
O
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
RELA |
RELA, NFKB3: Transcription factor p65 |
13.230 |
Evidence |
|
| ARHGEF6 |
ARHGEF6, COOL2, KIAA0006, PIXA: Rho guanine nucleotide exchange factor 6 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
13.230 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
SYK |
SYK: Tyrosine-protein kinase SYK |
13.2 |
Evidence |
|
| CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
13.2 |
Evidence |
O
|
| STAM2 |
STAM2: Signal transducing adapter molecule 2 |
EPS15 |
EPS15, AF1P: Epidermal growth factor receptor substrate 15 |
13.2 |
Evidence |
|
| APOA1 |
APOA1: Apolipoprotein A-I precursor |
TTR |
TTR, PALB: Transthyretin precursor |
13.120 |
Evidence |
|
| DAPP1 |
IPI00004301 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
13.120 |
Evidence |
|
| LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
DEF6 |
DEF6, IBP: Differentially expressed in FDCP 6 |
13.120 |
Evidence |
|
| NBN |
NBN, NBS, NBS1, P95: Nibrin |
RAD50 |
RAD50: DNA repair protein RAD50 |
13.010 |
Evidence |
|
| CCR5 |
CCR5: CCR5 receptor (Fragment) |
STAT3 |
|
13.010 |
Evidence |
|
| PSEN1 |
PSEN1, AD3, PS1, PSNL1: Presenilin-1 |
CASP6 |
CASP6, MCH2: Caspase-6 precursor |
13.010 |
Evidence |
|